This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suswam, E. Articles by King, P. H. Search for Related Content PubMed PubMed Citation Articles by Suswam, E. Articles by King, P. H.

Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells

Departments of ¹ Neurology, ² Genetics, ³ Physiology and Biophysics, ⁴ Cell Biology, ⁵ Pathology, and ⁶ Surgery, University of Alabama and ⁷ Birmingham Veterans Affairs Medical Center, Birmingham, Alabama

Requests for reprints: Peter H. King, University of Alabama at Birmingham Department of Neurology, SC 200, 1530 3rd Avenue South, Birmingham, AL 35294-0017. Phone: 205-975-8116; Fax: 205-996-7255; E-mail: pking{at}uab.edu.

Key Words: RNA-protein interactions • Brain/central nervous system cancers • Posttranscriptional and translational control

Malignant gliomas are highly aggressive tumors of the central nervous system that rely on production of growth factors for tumor progression. Vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), and tumor necrosis factor-, for example, are up-regulated in these tumors to promote angiogenesis and proliferation. RNA stability, mediated through adenine and uridine-rich elements (ARE) in the 3' untranslated region, is a critical control point for regulating these growth factors. RNA half-life is predominantly governed by a balance between stabilizing and destabilizing factors that bind to ARE. We have previously shown that the stabilizing factor HuR is overexpressed in malignant gliomas and linked to RNA stabilization of angiogenic growth factors. Here, we report that the destabilizing factor tristetraprolin (TTP) is also ubiquitously expressed in primary malignant glioma tissues and cell lines. In contrast to benign astrogliotic tissues, however, the protein was hyperphosphorylated, with evidence implicating the p38/mitogen-activated protein kinase (MAPK) pathway. Conditional overexpression of TTP as a transgene in malignant glioma cells led to RNA destabilization of IL-8 and VEGF and down-regulation of protein production. Analysis of in vivo RNA binding indicated a shift of mRNA toward ectopic TTP and away from endogenous HuR. This biochemical phenotype was associated with a decrease in cell proliferation, loss of cell viability, and apoptosis. We postulate that hyperphosphorylation of TTP via p38/MAPK promotes progression of malignant gliomas by negatively regulating its RNA destabilizing function. [Cancer Res 2008;68(3):674–82]

This article has been cited by other articles:

				S. E. Brennan, Y. Kuwano, N. Alkharouf, P. J. Blackshear, M. Gorospe, and G. M. Wilson The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis Cancer Res., June 15, 2009; 69(12): 5168 - 5176. [Abstract] [Full Text] [PDF]

				W. Al-Ahmadi, M. Al-Ghamdi, L. Al-Haj, M. Al-Saif, and K. S. A. Khabar Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation Nucleic Acids Res., June 1, 2009; 37(11): 3612 - 3624. [Abstract] [Full Text] [PDF]